Chagrin Falls, OH, United States of America

Stephen Rundlett

This inventor holds 13 USPTO granted patents and 1 published patent application. Top assignees: Athersys, Inc., Abt Holding Company. Active years: 2002-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Rundlett. Retrieved from https://idiyas.com/inventor/stephen-rundlett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 92.3

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 115(Granted Patents)

Company Filing History:

Years Active: 2002-2010

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7842792 - Compositions and methods for non-targeted activation of endogenous genes (2010-11-30),

2. 7569220 - Compositions and methods for non-targeted activation of endogenous genes (2009-08-04),

3. 7420044 - Nucleic acid and protein homologs and uses thereof (2008-09-02),

4. 7316923 - Compositions and methods for non-targeted activation of endogenous genes (2008-01-08),

5. 6740503 - Compositions and methods for non-targeted activation of endogenous genes (2004-05-25),

6. 6670185 - Compositions and methods for non-targeted activation of endogenous genes (2003-12-30),

7. 6623958 - Compositions and methods for non-targeted activation of endogenous genes (2003-09-23),

8. 6602686 - Compositions and method for non-targeted activation of endogenous genes (2003-08-05),

9. 6541221 - Compositions and methods for non-targeted activation of endogenous genes (2003-04-01),

10. 6524824 - Compositions and methods for non-targeted activation of endogenous genes (2003-02-25),

11. 6524818 - Compositions and methods for non-targeted activation of endogenous genes (2003-02-25),

12. 6410266 - Compositions and methods for non-targeted activation of endogenous genes (2002-06-25),

13. 6361972 - Compositions and methods for non-targeted activation of endogenous genes (2002-03-26),

Title: The Innovative Contributions of Stephen Rundlett

Introduction

Stephen Rundlett is a notable inventor based in Chagrin Falls, Ohio. He has made significant contributions to the field of gene expression and biotechnology, holding a total of 13 patents. His work focuses on innovative methods for activating endogenous genes, which have implications for understanding human diseases and development.

Latest Patents

Rundlett's latest patents include compositions and methods for non-targeted activation of endogenous genes. This invention is directed towards activating gene expression or causing over-expression of a gene through recombination methods in situ. The invention outlines methods for expressing an endogenous gene in a cell at levels higher than those typically found. One embodiment involves the activation of an endogenous gene following the integration of a regulatory sequence that enhances gene expression. Additionally, the invention allows for the identification, activation, isolation, and expression of genes that are not discoverable by current methods, as it does not require a target sequence for integration. This advancement enables the activation and isolation of endogenous genes associated with human disease and development without prior knowledge of their sequence or function.

Career Highlights

Throughout his career, Stephen Rundlett has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Athersys, Inc. and Abt Holding Company. His experience in these organizations has contributed to his expertise in gene expression technologies and innovative research methodologies.

Collaborations

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: